Estrogen Agonist/Antagonist class drugs
7 results
Clomiphene citrate (clomiphene citrate)
(Clomiphene Citrate)Advagen Pharma Ltd
Usage: Clomiphene citrate is indicated for treating ovulatory dysfunction in women seeking pregnancy. It is effective for conditions like polycystic ovary syndrome and certain amenorrhea cases. Patients must not be pregnant, have ovarian cysts or abnormal bleeding, and should have normal liver function before therapy.
Clomiphene citrate (clomiphene citrate)
(Clomiphene Citrate)Par Pharmaceutical, Inc.
Usage: Clomiphene citrate is indicated for treating ovulatory dysfunction in women seeking pregnancy. It is effective in patients with conditions like polycystic ovary syndrome and certain amenorrheas. Proper evaluation and exclusion of pregnancy or ovarian cysts are essential before treatment. Long-term use beyond six cycles is not recommended.
Osphena (ospemifene)
(Ospemifene)Shionogi Inc.
Usage: OSPHENA is indicated for the treatment of moderate to severe dyspareunia and vaginal dryness, both symptoms associated with vulvar and vaginal atrophy due to menopause.
Raloxifene hydrochloride (raloxifene hydrochloride)
(Raloxifene hydrochloride)ScieGen Pharmaceuticals Inc
Usage: Raloxifene hydrochloride tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women, and for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk of breast cancer. Regular breast exams and mammograms are recommended during treatment.
Raloxifene hydrochloride (raloxifene)
(Raloxifene)Cipla USA Inc.
Usage: Raloxifene hydrochloride tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women, and for reducing the risk of invasive breast cancer in both postmenopausal women with osteoporosis and those at high risk for the disease.
Tamoxifen citrate (tamoxifen citrate)
(Tamoxifen Citrate)A-S Medication Solutions
Usage: Tamoxifen citrate is indicated for treating metastatic breast cancer, adjuvant therapy post-surgery, and ductal carcinoma in situ (DCIS). It also reduces breast cancer incidence in high-risk women. Recommended for women with estrogen receptor-positive tumors, it offers tailored therapy based on individual risk assessments.
Tamoxifen citrate (tamoxifen citrate)
(Tamoxifen Citrate)Zydus Lifesciences Limited